| Document and Entity Information | Nov. 11, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Nov. 11, 2024 |
| Entity Registrant Name | Spruce Biosciences, Inc. |
| Entity Central Index Key | 0001683553 |
| Entity Emerging Growth Company | true |
| Entity Ex Transition Period | false |
| Entity File Number | 001-39594 |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 81-2154263 |
| Entity Address, Address Line One | 611 Gateway Boulevard |
| Entity Address, Address Line Two | Suite 740 |
| Entity Address, City or Town | South San Francisco |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 94080 |
| City Area Code | 415 |
| Local Phone Number | 655-4168 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, par value $0.0001 per share |
| Trading Symbol | SPRB |
| Security Exchange Name | NASDAQ |
